Inhibition of FAO in AML co-cultured with BM adipocytes: mechanisms of survival and chemosensitization to cytarabine

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Inhibition of FAO in AML co-cultured with BM adipocytes: mechanisms of survival and chemosensitization to cytarabine ; volume:8 ; number:1 ; day:15 ; month:11 ; year:2018 ; pages:1-12 ; date:12.2018
Scientific reports ; 8, Heft 1 (15.11.2018), 1-12, 12.2018

Creator: Tabe, Yoko
Saitoh, Kaori
Yang, Haeun
Sekihara, Kazumasa
Yamatani, Kotoko
Ruvolo, Vivian
Taka, Hikari
Kaga, Naoko
Kikkawa, Mika
Arai, Hajime
Miida, Takashi
Andreeff, Michael
Spagnuolo, Paul A.
Konopleva, Marina

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-018-35198-6

URN: urn:nbn:de:101:1-2018122723165284179981

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:54 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Tabe, Yoko
Saitoh, Kaori
Yang, Haeun
Sekihara, Kazumasa
Yamatani, Kotoko
Ruvolo, Vivian
Taka, Hikari
Kaga, Naoko
Kikkawa, Mika
Arai, Hajime
Miida, Takashi
Andreeff, Michael
Spagnuolo, Paul A.
Konopleva, Marina
SpringerLink (Online service)

Other Objects (12)

Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment

Hochschulschrift

Genome-wide CRISPR/Cas9 combined cytarabine resistance and sensitizer screen in AML cell lines, [Band].

Medium-cumulative dose of cytarabine in consolidation therapy shows the greatest benefit in AML patients

Manipulation of SAMHD1 using lentiviral protein Vpx to increase sensitivity of AML cells to cytarabine

Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML

Disrupting the LC3 interaction region (LIR) binding of selective autophagy receptors sensitizes AML cell lines to cytarabine

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

Successful fat-only whole breast reconstruction using cultured mature adipocytes and conditioned medium containing MCP-1

EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax

Cytarabine-induced differentiation of AML cells depends on Chk1 activation and shares the mechanism with inhibitors of DHODH and pyrimidine synthesis

Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment

Hochschulschrift

Genome-wide CRISPR/Cas9 combined cytarabine resistance and sensitizer screen in AML cell lines, [Band].

Medium-cumulative dose of cytarabine in consolidation therapy shows the greatest benefit in AML patients

Manipulation of SAMHD1 using lentiviral protein Vpx to increase sensitivity of AML cells to cytarabine

Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML

Disrupting the LC3 interaction region (LIR) binding of selective autophagy receptors sensitizes AML cell lines to cytarabine

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

Successful fat-only whole breast reconstruction using cultured mature adipocytes and conditioned medium containing MCP-1

EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax

Cytarabine-induced differentiation of AML cells depends on Chk1 activation and shares the mechanism with inhibitors of DHODH and pyrimidine synthesis

Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment

Hochschulschrift

Genome-wide CRISPR/Cas9 combined cytarabine resistance and sensitizer screen in AML cell lines, [Band].

Medium-cumulative dose of cytarabine in consolidation therapy shows the greatest benefit in AML patients

Manipulation of SAMHD1 using lentiviral protein Vpx to increase sensitivity of AML cells to cytarabine

Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML

Disrupting the LC3 interaction region (LIR) binding of selective autophagy receptors sensitizes AML cell lines to cytarabine

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

Successful fat-only whole breast reconstruction using cultured mature adipocytes and conditioned medium containing MCP-1

EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax

Cytarabine-induced differentiation of AML cells depends on Chk1 activation and shares the mechanism with inhibitors of DHODH and pyrimidine synthesis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Inhibition of FAO in AML co-cultured with BM adipocytes: mechanisms of survival and chemosensitization to cytarabine

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment

Genome-wide CRISPR/Cas9 combined cytarabine resistance and sensitizer screen in AML cell lines, [Band].

Medium-cumulative dose of cytarabine in consolidation therapy shows the greatest benefit in AML patients

Manipulation of SAMHD1 using lentiviral protein Vpx to increase sensitivity of AML cells to cytarabine

Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML

Disrupting the LC3 interaction region (LIR) binding of selective autophagy receptors sensitizes AML cell lines to cytarabine

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

Successful fat-only whole breast reconstruction using cultured mature adipocytes and conditioned medium containing MCP-1

EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax

Cytarabine-induced differentiation of AML cells depends on Chk1 activation and shares the mechanism with inhibitors of DHODH and pyrimidine synthesis

Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment

Genome-wide CRISPR/Cas9 combined cytarabine resistance and sensitizer screen in AML cell lines, [Band].

Medium-cumulative dose of cytarabine in consolidation therapy shows the greatest benefit in AML patients

Manipulation of SAMHD1 using lentiviral protein Vpx to increase sensitivity of AML cells to cytarabine

Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML

Disrupting the LC3 interaction region (LIR) binding of selective autophagy receptors sensitizes AML cell lines to cytarabine

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

Successful fat-only whole breast reconstruction using cultured mature adipocytes and conditioned medium containing MCP-1

EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax

Cytarabine-induced differentiation of AML cells depends on Chk1 activation and shares the mechanism with inhibitors of DHODH and pyrimidine synthesis

Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment

Genome-wide CRISPR/Cas9 combined cytarabine resistance and sensitizer screen in AML cell lines, [Band].

Medium-cumulative dose of cytarabine in consolidation therapy shows the greatest benefit in AML patients

Manipulation of SAMHD1 using lentiviral protein Vpx to increase sensitivity of AML cells to cytarabine

Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML

Disrupting the LC3 interaction region (LIR) binding of selective autophagy receptors sensitizes AML cell lines to cytarabine

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

Successful fat-only whole breast reconstruction using cultured mature adipocytes and conditioned medium containing MCP-1

EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax

Cytarabine-induced differentiation of AML cells depends on Chk1 activation and shares the mechanism with inhibitors of DHODH and pyrimidine synthesis

Related objects

Reset password